Comparison of Phenotypic Methods for the Identification of Candida dubliniensis

Journal of Microbiology, Immunology and Infection

Volumn 43, Issue 2, 2010, Pages 147-154

  Pasligh, Julia ^a   Radecke, Clarissa ^a   Fleischhacker, Michael ^a   Ruhnke, Markus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

AP PCR; API ID 32C; Bird seed agar; Candida dubliniensis; CHROMagar Candida

Indexed keywords

PALATINOSE;

AGAR MEDIUM; ANALYTIC METHOD; ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FUNGAL DETECTION; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS IDENTIFICATION; GENOTYPE; HEAT SENSITIVITY; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPECIES DIFFERENCE; STRAIN IDENTIFICATION;

CANDIDA; CANDIDIASIS; DNA FINGERPRINTING; GENOTYPE; HUMANS; MYCOLOGICAL TYPING TECHNIQUES; PHENOTYPE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 77951808225     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1684-1182(10)60023-0     Document Type: Article

References (50)

1. Pfaller M.A., and Diekema D.J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20 (2007) 133-163
2. Pappas P.G. Invasive candidiasis. Infect Dis Clin North Am 20 (2006) 485-506
3. Kauffman C.A. Candiduria. Clin Infect Dis 41 Supp l (2005) S371-S376
4. Sims C.R., Ostrosky-Zeichner L., and Rex J.H. Invasive candidiasis in immunocompromized hospitalized patients. Arch Med Res 36 (2005) 660-671
5. Donelli G. Vascular catheter-related infection and sepsis. Surg Infect (Larchmt) 7 Suppl (2006) S25-S27
6. Ellepola A.N., and Morrison C.J. Laboratory diagnosis of invasive candidiasis. J Microbiol 43 (2005) 65-84
7. Jensen J., Munoz P., Guinea J., Rodriguez-Creixems M., Pelaez T., and Bouza E. Mixed fungemia: incidence, risk factors, and mortality in a general hospital. Clin Infect Dis 44 (2007) e109-e114
8. Campanha N.H., Neppelenbroek K.H., Spolidorio D.M., Spolidorio L.C., and Pavarina A.C. Phenotypic methods and commercial systems for the discrimination between C. albicans and C. dubliniensis. Oral Dis 11 (2005) 392-398
9. Giammanco G.M., Pizzo G., Pecorella S., Distefano S., Pecoraro V., and Milici M.E. Identification of Candida dubliniensis among oral yeast isolates from an Italian population of human immunodeficiency virus-infected (HIV +) subjects. Oral Microbiol Immunol 17 (2002) 89-94
10. Kirkpatrick W.R., Revankar S.G., Mcatee R.K., Lopez-Ribot J.L., Fothergill A.W., McCarthy D.I., et al. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar® Candida screening and susceptibility testing of isolates. J Clin Microbiol 36 (1998) 3007-3012
11. Sullivan D., and Coleman D. Candida dubliniensis: an emerging opportunistic pathogen. Curr Top Med Mycol 8 (1997) 15-25
12. Salkin I.F., Pruitt W.R., Padhye A.A., Sullivan D., Coleman D., and Pincus D.H. Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States. J Clin Microbiol 36 (1998) 1467
13. Alves S.H., Milan E.P., Branchini M.L., Nishimura K., Fukushima K., Oliveira L.O., et al. First isolation of Candida dubliniensis in Rio Grande do Sul, Brazil. Diagn Microbiol Infect Dis 39 (2001) 165-168
14. Al M.A., Sullivan D.J., Polacheck I., Shaheen F.A., Soliman O., Al H.S., et al. Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting. J Clin Microbiol 43 (2005) 4026-4036
15. Meis J.F., Ruhnke M., De Pauw B.E., Odds F.C., Siegert W., and Verweij P.E. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg Infect Dis 5 (1999) 150-153
16. Sullivan D.J., Westerneng T.J., Haynes K.A., Bennett D.E., and Coleman D.C. Candida dubliniensis sp. nov: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141 (1995) 1507-1521
17. Meiller T.F., Jabra-Rizk M.A., Baqui A., Kelley J.I., Meeks V.I., Merz W.G., et al. Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States. Oral Surg Oral Med Oral Pathol Oral Radio Endod 88 (1999) 573-580
18. Coleman D., Sullivan D., Harrington B., Haynes K., Henman M., Shanley D., et al. Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients. Oral Dis 3 Suppl 1 (1997) S96-S101
19. Fotedar R., and Al Hedaithy S.S. Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients. Mycoses 47 (2004) 150-155
20. Polacheck I., Strahilevitz J., Sullivan D., Donnelly S., Salkin I.F., and Coleman D.C. Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel. J Clin Microbiol 38 (2000) 170-174
21. Kim J.O., Garofalo L., Blecker-Shelly D., and McGowan K.L. Candida dubliniensis infections in a pediatric population: retrospective identification from clinical laboratory isolates of Candida albicans. J Clin Microbiol 41 (2003) 3354-3357
22. Carr M.J., Clarke S., O'Connell F., Sullivan D.J., Coleman D.C., and O'Connell B. First reported case of endocarditis caused by Candida dubliniensis. J Clin Microbiol 43 (2005) 3023-3026
23. Sullivan D., and Coleman D. Candida dubliniensis: characteristics and identification. J Clin Microbiol 36 (1998) 329-334
24. Schoofs A., Odds F.C., Colebunders R., Ieven M., and Goossens H. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Infect Dis 16 (1997) 296-300
25. Odds F.C., and Bernaerts R. CHROMagar® Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 32 (1994) 1923-1929
26. Pincus D.H., Coleman D.C., Pruitt W.R., Padhye A.A., Salkin I.F., Geimer M., et al. Rapid identification of Candida dubliniensis with commercial yeast identification systems. J Clin Microbiol 37 (1999) 3533-3539
27. Willinger B., Hillowoth C., Selitsch B., and Manafi M. Performance of candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROMagar® Candida. J Clin Microbiol 39 (2001) 3793-3835
28. Welsh J., and McClelland M. Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res 18 (1990) 7213-7218
29. Akopyanz N., Bukanov N.O., Westblom T.U., Kresovich S., and Berg D.E. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res 20 (1992) 5137-5142
30. Staib P., and Morschhauser J. Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis. Mycoses 42 (1999) 521-524
31. Pinjon E., Sullivan D., Salkin I., Shanley D., and Coleman D. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol 36 (1998) 2093-2095
32. Joly S., Pujol C., Rysz M., Vargas K., and Soll D.R. Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis. J Clin Microbiol 37 (1999) 1035-1044
33. Jabra-Rizk M.A., Brenner T.M., Romagnoli M., Baqui A.A., Merz W.G., Falkler Jr. W.A., et al. Evaluation of a reformulated CHROMagar® Candida. J Clin Microbiol 39 (2001) 2015-2016
34. Momani O.M., and Qaddoomi A. Identification of Candida dubliniensis in a diagnostic microbiology laboratory. East Mediterr Health J g11 (2005) 366-371
35. Hospenthal D.R., Beckius M.L., Floyd K.L., Horvath L.L., and Murray C.K. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar® Candida. Ann Clin Microbiol Antimicrob 5 (2006) 1
36. Sahand I.H., Moragues M.D., Eraso E., Villar-Vidal M., Quindos G., and Ponton J. Supplementation of CHROMagar® Candida medium with Pal's medium for rapid identification of Candida dubliniensis. J Clin Microbiol 43 (2005) 5768-5770
37. Mesa L.M., Arcaya N., Canas O., Machado Y., and Calvo B. Phenotypic evaluation to differentiate Candida albicans from Candida dubliniensis. Rev Iberoam Micol 21 (2004) 135-138
38. Mahnss B., Stehr F., Schafer W., and Neuber K. Comparison of standard phenotypic assays with a PCR method to discriminate Candida albicans and C. dubliniensis. Mycoses 48 (2005) 55-61
39. Odds F.C., and Davidson A. "Room temperature" use of CHROMagar® Candida. Diagn Microbiol Infect Dis 38 (2000) 147-150
40. Eraso E., Moragues M.D., Villar-Vidal M., Sahand I.H., Gonzalez-Gomez N., Ponton J., et al. Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species. J Clin Microbiol 44 (2006) 3340-3345
41. Al Mosaid A., Sullivan D., Salkin I.F., Shanley D., and Coleman D.C. Differentiation of Candida dubliniensis from Candida albicans on staib agar and caffeic acid-ferric citrate agar. J Clin Microbiol 39 (2001) 323-327
42. Sancak B., Colakoglu S., Acikgoz Z.C., and Arikan S. Incubation at room temperature may be an independent factor that induces chlamydospore production in Candida dubliniensis. Diagn Microbiol Infect Dis 52 (2005) 305-309
43. Tintelnot K., Haase G., Seibold M., Bergmann F., Staemmler M., Franz T., et al. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J Clin Microbiol 38 (2000) 1599-1608
44. Caniaux I., Villard J., and Gayral J.P. Détection automatisée de l'assimilation des sources de carbone par les levres. Bulletin de la Sociéte Francaise de Mycologie Medicale 14 (1985) 269-276
45. Alves S.H., Horta J.A., Milan E.P., Scheid L.A., Vainstein M.H., Santurio J.M., et al. Carbohydrate assimilation profiles of Brazilian Candida dubliniensis isolates based on ID 32C system. Rev Inst Med Trop Sao Paulo 47 (2005) 109-111
46. Kurzai O., Korting H.C., Harmsen D., Bautsch W., Molitor M., Frosch M., et al. Molecular and phenotypic identification of the yeast pathogen Candida dubliniensis. J Mol Med 78 (2000) 521-529
47. Xu J., Millar B.C., Moore J.E., McClurg R., Walker M.J., Evans J., et al. Comparison of API20C with molecular identification of Candida spp isolated from bloodstream infections. J Clin Pathol 55 (2002) 774-777
48. Marot-Leblond A., Beucher B., David S., Nail-Billaud S., and Robert R. Development and evaluation of a rapid latex agglutination test using a monoclonal antibody to identify Candida dubliniensis colonies. J Clin Microbiol 44 (2006) 138-142
49. Sahand I.H., Moragues M.D., Robert R., Quindos G., and Ponton J. Evaluation of Bichro-Dubli Fumouze to distinguish Candida dubliniensis from Candida albicans. Diagn Microbiol Infect Dis 55 (2006) 165-167
50. Chryssanthou E., Fernandez V., and Petrini B. Performance of commercial latex agglutination tests for the differentiation of Candida dubliniensis and Candida albicans in routine diagnostics. APMIS 115 (2007) 1281-1284